ARTICLE | Company News
Lilly, IntelGenx deal
December 2, 2016 9:49 PM UTC
Eli Lilly granted IntelGenx rights to U.S. Patent No. 6,943,166, which covers dosing of Lilly’s tadalafil. IntelGenx says the deal will allow it to commercialize its Tadalafil ED Versafilm in the U.S....
BCIQ Target Profiles